Form 6K CASI Pharmaceuticals Inc For: 23 December
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
CASI Pharmaceuticals Inc (CASI)
Assess today's live CASI Pharmaceuticals Inc (CASI) share price, performance and insights using our live NASDAQ: CASI stock exchange data.
Analyse the historical data and CASI Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Casi Pharma share price buy/sell indicators using real-time data (or discuss the Casi Pharma (CASI) stock price today with other investors in the Casi Pharma NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CASI share price (ISIN: KYG1933S1012) to enhance your trading decisions with our free investment tools and resources.
What Is the CASI Pharmaceuticals Inc Share Price Today?
The Casi Pharma share price today is 0.7532.
What Is the Stock Symbol for CASI Pharmaceuticals Inc
The stock symbol (or 'ticker') for CASI Pharmaceuticals Inc is "CASI."
What Stock Exchange Does CASI Pharmaceuticals Inc Trade On?
CASI Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is CASI Pharmaceuticals Inc a Good Stock to Buy?
Determining whether CASI Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and CASI Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Casi Pharma share price buy/sell indicators using real-time data (or discuss the Casi Pharma (CASI) stock price today with other investors in the Casi Pharma NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CASI share price (ISIN: KYG1933S1012) to enhance your trading decisions with our free investment tools and resources.
What Is the CASI Pharmaceuticals Inc Share Price Today?
The Casi Pharma share price today is 0.7532.
What Is the Stock Symbol for CASI Pharmaceuticals Inc
The stock symbol (or 'ticker') for CASI Pharmaceuticals Inc is "CASI."
What Stock Exchange Does CASI Pharmaceuticals Inc Trade On?
CASI Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is CASI Pharmaceuticals Inc a Good Stock to Buy?
Determining whether CASI Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.7520
0.8501
52 wk Range
0.7520
3.4700
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.75200.8501
52 wk Range
0.75203.4700
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CASI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
4.0000
Upside
+431.07%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Form 6K CASI Pharmaceuticals Inc For: 23 December
- Investing.com
- Form 6K CASI Pharmaceuticals Inc For: 11 December
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Casi Pharma Company Profile
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People’s Republic of China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation and as a palliative treatment for patients with multiple myeloma. The company’s hematology/oncology assets in pipeline include CNCT19, an autologous CD19 CAR-T investigative product; BI-1206, an novel anti-Fc?RIIB antibody for the treatment of solid tumors and relapsed/refractory non-hodgkin lymphoma; CB-5339, a novel VCP/p97 inhibitor that focuses on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis, DNA damage response, and other cellular stress pathways for therapeutic use in the treatment of patients with various malignancies; CID-103, a human IgG1 anti-CD38 monoclonal antibody; and Thiotepa, a chemotherapeutic agent, which has various indications, including use as a conditioning treatment for use prior to certain allogeneic haemopoietic stem cell transplants. It has licensing agreements with Juventas Cell Therapy Ltd.; BioInvent International AB; Black Belt Therapeutics Limited; Cleave Therapeutics, Inc.; and Acrotech Biopharma L.L.C. to develop and commercialize its commercial product EVOMELA. CASI Pharmaceuticals, Inc. was incorporated in 1991 and is based in Beijing, the People’s Republic of China.
Compare CASI to Peers and Sector
Metrics to compare | CASI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCASIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.3x | −2.8x | −0.6x | |
PEG Ratio | 0.01 | −0.01 | 0.00 | |
Price/Book | −0.5x | 3.9x | 2.6x | |
Price / LTM Sales | 0.6x | 10.7x | 3.2x | |
Upside (Analyst Target) | - | 215.6% | 41.8% | |
Fair Value Upside | Unlock | 3.1% | 5.1% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 4.0000
(+431.07% Upside)
Earnings
Latest Release
Nov 14, 2025
EPS / Forecast
-0.68 / -0.60
Revenue / Forecast
3.08M / --
People Also Watch
FAQ
What Is the Casi Pharma (CASI) Share Price Today?
The live Casi Pharma share price today is 0.7532
What Stock Exchange Does Casi Pharma (CASI) Trade On?
Casi Pharma is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Casi Pharma?
The stock symbol (also called a 'ticker') for Casi Pharma is "CASI."
What Is the Current Casi Pharma Market Cap?
As of today, Casi Pharma market capitalisation is 15.48M.
What Is Casi Pharma's (CASI) Earnings Per Share (TTM)?
The Casi Pharma EPS is currently -2.98 (Trailing Twelve Months).
Is CASI a Buy or Sell From a Technical Analyst Perspective?
Based on today's Casi Pharma moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Casi Pharma Stock Split?
Casi Pharma has split 2 times. (See the CASI stock split history page for full effective split date and price information.)
How Many Employees Does Casi Pharma Have?
Casi Pharma has 233 employees.
What is the current trading status of Casi Pharma (CASI)?
As of 24 Dec 2025, Casi Pharma (CASI) is trading at a price of 0.7532, with a previous close of 0.8003. The stock has fluctuated within a day range of 0.7520 to 0.8501, while its 52-week range spans from 0.7520 to 3.4700.
What Is Casi Pharma (CASI) Price Target According to Analysts?
The average 12-month price target for Casi Pharma is USD4, with a high estimate of USD4 and a low estimate of USD4. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +431.07% Upside potential.
What Is the CASI After Hours Price?
CASI's last after hours stock price is 0.7520, the stock has decreased by -0.0012, or -0.1600%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.